RKVTF (Rakovina Therapeutics) Shares Outstanding (Diluted Average): 24.41 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RKVTF Rakovina Therapeutics Inc RKVTF
10 GF Score
Price $0.13
! 1 Warning Sign
View Full Analysis

What is Rakovina Therapeutics Shares Outstanding (Diluted Average)?

Rakovina Therapeutics RKVTF -14.83% 10 Shares Outstanding (Diluted Average) is 24.41 Mil as of Jun. 2026. GuruFocus rates RKVTF with a GF Score™ of 10/100. The stock has 1 warning sign investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Rakovina Therapeutics's average diluted shares outstanding for the quarter that ended in Jun. 2026 was 24.41 Mil.


Rakovina Therapeutics  (OTCPK:RKVTF) Shares Outstanding (Diluted Average) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.


Be Aware

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Rakovina Therapeutics Shares Outstanding (Diluted Average) Related Terms


Rakovina Therapeutics Shares Outstanding (Diluted Average) Historical Data

* Premium members only.

The historical data trend for Rakovina Therapeutics's Shares Outstanding (Diluted Average) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rakovina Therapeutics Shares Outstanding (Diluted Average) Chart

Rakovina Therapeutics Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (Diluted Average)
5.36 6.98 6.99 8.26 18.10

Rakovina Therapeutics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shares Outstanding (Diluted Average) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.91 21.15 21.18 22.13 24.41
RKVTF
10GF Score
Rakovina Therapeutics Inc RKVTF
Shares Outstanding (Diluted Average) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rakovina Therapeutics Shares Outstanding (Diluted Average) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that exact time point. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (Diluted Average) of 24.41 Mil mean?
Rakovina Therapeutics (RKVTF) has a Shares Outstanding (Diluted Average) of 24.41 Mil as of Jun. 2026. The average shares outstanding over two periods including dilutive securities like preferred shares and convertibles. View historical data on Rakovina Therapeutics and its competitors.
Is Rakovina Therapeutics' Shares Outstanding (Diluted Average) too high?
Rakovina Therapeutics' current Shares Outstanding (Diluted Average) is 24.41 Mil. Overall, Rakovina Therapeutics has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Rakovina Therapeutics' Shares Outstanding (Diluted Average) compare to VRTX and REGN?
Rakovina Therapeutics' Shares Outstanding (Diluted Average) of 24.41 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (Diluted Average) for a Biotechnology company?
A good Shares Outstanding (Diluted Average) depends on the Biotechnology industry context. However, Shares Outstanding (Diluted Average) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (Diluted Average) mean?
A high Shares Outstanding (Diluted Average) can signal that a stock is expensive relative to its fundamentals. The average shares outstanding over two periods including dilutive securities like preferred shares and convertibles. View historical data on Rakovina Therapeutics and its competitors. Rakovina Therapeutics's current Shares Outstanding (Diluted Average) is 24.41 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rakovina Therapeutics stock overvalued right now?
Rakovina Therapeutics (RKVTF) has a current Shares Outstanding (Diluted Average) of 24.41 Mil. The current Shares Outstanding (Diluted Average) is 24.41 Mil. Rakovina Therapeutics' overall GF Score™ is 10/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (Diluted Average) calculated?
Shares Outstanding (Diluted Average) is calculated from a company's financial statements. For Rakovina Therapeutics (RKVTF), the current Shares Outstanding (Diluted Average) is 24.41 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rakovina Therapeutics Business Description

Other Exchanges 7JO0:GermanyRKV:Canada
Address 999 West Broadway, Suite 720, Vancouver, BC, CAN, V5Z 1K5
Rakovina Therapeutics Inc is a biopharmaceutical research company focused on the development of cancer treatments. Its work is based on technologies for targeting the DNA-damage response powered by Artificial Intelligence (AI) using proprietary, generative AI platforms. By using AI, it can review and optimize drug candidates at a greater pace. The company has established a pipeline of distinctive DNA-damage response inhibitors to advance one or more drug candidates into human clinical trials in collaboration with pharmaceutical partners. Its drug development pipeline consists of candidates like kt-5000AI, kt-2000AI, and kt-3283, targeting solid tumours and PARP-resistant adult and childhood cancers.
10GF Score

Get the complete analysis for RKVTF

Shares Outstanding (Diluted Average) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.13
Price